{
  "pmcid": "12424048",
  "sha256": "ff86e2f8d76f6c54a6c62a5152b9833e1a1abcc0c7516e837690c523d0b955e1",
  "timestamp_utc": "2025-11-09T15:40:57.278590+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 17.492282157676353,
    "reading_ease": 2.6707436961378903,
    "word_count": 241
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "This study describes occult lesion clinical data and evaluates characteristics so that surgeons can better incorporate this emerging technology into clinical decision making."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants (n = 100) enrolled in a phase 3 trial of IMI with pafolacianine during pulmonary resection"
      },
      "Participants": {
        "score": 1,
        "evidence": "Participants (n = 100) enrolled in a phase 3 trial of IMI with pafolacianine during pulmonary resection"
      },
      "Intervention": {
        "score": 2,
        "evidence": "phase 3 trial of IMI with pafolacianine during pulmonary resection"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study describes occult lesion clinical data and evaluates characteristics so that surgeons can better incorporate this emerging technology into clinical decision making."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants (n = 100) enrolled in a phase 3 trial"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "IMI identified 29 occult lesions in 23 (23%) participants."
      },
      "Harms": {
        "score": 1,
        "evidence": "There was no additional morbidity in participants with lesions resected."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Enabling Lung Cancer Identification Using Folate Receptor Targeting [ELUCIDATE]; NCT04241315"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}